RU

Rajesh Utreja

Active Director Director DIN 02629851
DIN 02629851 First appointment Jan 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 2003
Shareholding value •••• Premium profile

About Rajesh Utreja

Data last updated:

Rajesh Utreja is a Director at Capsoft Healthcare Private Limited (since 2020), Additional Director at Immortal Biotech Private Limited (since 2014) and Director at Avvic Sciences India Private Limited (since 2020), and holds 1 more current directorship. The companies operate in Pharma, Chemicals and Internet. The 2 current companies with reported revenue have a combined latest revenue of ₹41.65 Cr; the largest is Capsoft Healthcare Private Limited at ₹41.08 Cr (FY 2025). Earlier, Rajesh Utreja was a Director at Immortal Remedies Private Limited (2021–2022) and Director at Kalprishi Healthways Private Limited (2018–2019).

DIN 02629851
Primary Designation Director
Industry Pharma
First Appointment 09 Jan 2003
Oldest Company Age 23 yrs
Largest company Capsoft Healthcare Private Limited · ₹41.08 Cr (FY 2025)
Combined revenue ₹41.65 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Capsoft Healthcare Private Limited U74999HP2020PTC007952
Director28 Jul 20202020₹41.08 Cr (FY 2025)Active
Immortal Biotech Private Limited U24100HR2014PTC052081
Additional Director29 Jul 20142014₹56.7 Lakh (FY 2022)Active
Avvic Sciences India Private Limited U51909UP2020PTC127203
Director04 Jun 20202020Active
Ecstasy Biotech Private Limited U24239DL2003PTC123968
Director09 Jan 20032003Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Immortal Remedies Private Limited U24293HR2021PTC097198
Director25 Aug 20212021Active
Kalprishi Healthways Private Limited U74999HR2018PTC074781
Director29 Jun 20182018₹87 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Immortal Biotech Private Limited
Ecstasy Biotech Private Limited
Avvic Sciences India Private Limited
Capsoft Healthcare Private Limited
Premium access

Shareholding and investment profile for Rajesh Utreja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Utreja

Rajesh Utreja currently holds 4 directorships: Capsoft Healthcare Private Limited (Director, since 28 Jul 2020, revenue ₹41.08 Cr (FY 2025)); Immortal Biotech Private Limited (Additional Director, since 29 Jul 2014, revenue ₹56.7 Lakh (FY 2022)); Avvic Sciences India Private Limited (Director, since 04 Jun 2020); Ecstasy Biotech Private Limited (Director, since 09 Jan 2003).

Rajesh Utreja was first appointed on 09 Jan 2003 as Director at Ecstasy Biotech Private Limited. The most recent appointment on record is 25 Aug 2021 at Immortal Remedies Private Limited.

The 2 current companies of Rajesh Utreja that report revenue have a combined latest revenue of ₹41.65 Cr: Capsoft Healthcare Private Limited ₹41.08 Cr (FY 2025); Immortal Biotech Private Limited ₹56.7 Lakh (FY 2022).

Rajesh Utreja held 2 earlier board appointments: Immortal Remedies Private Limited (Director, 25 Aug 2021 to 29 Mar 2022); Kalprishi Healthways Private Limited (Director, 29 Jun 2018 to 07 Nov 2019).

The current boards of Rajesh Utreja's companies include Ankit Vashistha (Capsoft Healthcare Private Limited), Deepak Diwan (Capsoft Healthcare Private Limited), Gaurav Sehgal (Capsoft Healthcare Private Limited), Kamla Kar (Capsoft Healthcare Private Limited), Puneet Kumar (Capsoft Healthcare Private Limited), Sachin Aggarwal (Capsoft Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available